Sigyn Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Sigyn Therapeutics, Inc. reported Common Stock Shares Outstanding of 1.61 million shares for the year ending 2024.

  • Sigyn Therapeutics, Inc. showed an increase of +24.6% in Common Stock Shares Outstanding from 2023 to 2024.
  • This data is from Sigyn Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2014 to 2024), Sigyn Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 90.0%.
  • Historical annual values: Fiscal year 2024: 1.61 million shares | Fiscal year 2023: 1.29 million shares | Fiscal year 2023: 42.71 million shares | Fiscal year 2022: 956,595 shares | Fiscal year 2021: 37.30 million shares | Fiscal year 2020: 35.20 million shares | Fiscal year 2019: 500,000 shares | Fiscal year 2018: 81.27 million shares | Fiscal year 2017: 53.28 million shares | Fiscal year 2015: 34.32 million shares | Fiscal year 2014: 16.00 million shares.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: